Results 61 to 70 of about 95,573 (296)

Collecting Duct Carcinoma Presenting Uncommon Metastatic Features [PDF]

Tumori Journal, 2012
Collecting duct carcinoma (CDC) is a relatively rare subtype of renal cell carcinoma (RCC) which has an aggressive course with an extremely poor prognosis. Here we report on a case of CDC in a 29-year-old woman who showed rapid disease progression with some uncommon clinical features including extensive vertebral metastases and invasion of the spinal ...
Ke Cheng, Ye Chen, Feng Zhao, Feng Gao, Hai-Tao Men, Meng Qiu, Qiu Li, Feng Bi, Ji-Yan Liu   +8 more
openaire   +2 more sources

Metastatic collecting duct carcinoma of the kidney treated with sunitinib

World Journal of Surgical Oncology, 2011
Collecting duct carcinoma (CDC) of the kidney is a rare and aggressive malignant tumor arising from the distal collecting tubules which has been shown to have a poor response to several kinds of systemic therapy.
M'rabti Hind, Ahellal Youness, Tazi Mohamed, Essadi Ismail, Tazi El, Errihani Hassan   +5 more
doaj   +1 more source

Non-Surgical Biliary Drainage on Biliary Obstruction Due to Malignancy [PDF]

, 2001
Surgery is still the golden standard of curative therapy for Malignant biliary obstruction, but only 10- 20% of cases considered resectable. Therefore, palliative therapy to relieve pain, cholestasis, and biliary obstruction, is the main treatment for ...
Hasan, I. (Irsan), Lesmana, L. A. (L), Syam, A. F. (Ari), Tambunan, K. (Karmel), Yunihastuti, E. (Evy)   +4 more
core   +1 more source

Féloldali vese gyűjtőcsatornás daganatának eredményes palliatív kemoterápiás kezelése anuria mellett [PDF]

, 2016
Absztrakt A szerzők 54 éves nőbeteg esetét mutatják be. Kétoldali (Bellini-) gyűjtőcsatornából kiinduló, multiplex tüdőmetasztázisokat adó vesetumor miatt jobb oldali nephrectomia történt.
Culine, Stéphane, Kránitz, Noémi, Kullmann, Tamás, Pintér, Tamás, Szepesvári, Zsolt   +4 more
core   +1 more source

Extrarenal multiorgan metastases of collecting duct carcinoma of the kidney: A case series

Journal of Medical Case Reports, 2008
Introduction Collecting duct carcinoma is a rare type of renal cell carcinoma. The primary is difficult to diagnose on imaging, and metastases are often present on initial presentation.
Nakamura Hisao, Kuirhara Yasuyuki, Matsushita Kazuhiko, Sakai Akehide, Yamaguchi Toshio, Nakajima Yasuo   +5 more
doaj   +1 more source

Collecting Duct Carcinoma of the Kidney

British Journal of Urology, 1993
Summary— Collecting duct carcinoma (CDC) is a recently recognised histological variety of renal carcinoma (RC) considered to arise from the epithelium of the collecting ducts. Diagnosis of this entity depends on well defined gross and microscopic criteria and is supported by a characteristic immunostaining ...
Dimopoulos, MA, Logothetis, CJ, Markowitz, A, Sella, A, Amato, R, Ro, Jae   +5 more
openaire   +4 more sources

Carcinoma renal dos ductos de Bellini

Revista do Colégio Brasileiro de Cirurgiões
Two types primary epithelial tumours of the kidney have been distinguished, such as renal cell carcinoma (hypernephroma or Grawitz) deriving from proximal tubules and carcinoma arising in the urothelium of the kidney's collecting system. Mancilla-Jimenez
Helio Begliomini
doaj   +1 more source

Collecting Duct Renal Cell Carcinoma Found to Involve the Collecting System During Partial Nephrectomy: A Case Report

Journal of Kidney Cancer and VHL, 2015
Collecting duct carcinoma (CDC) is a rare and aggressive form of renal cell carcinoma (RCC) arising from the principal cells of the collecting duct.  One third of cases present with metastatic disease, but many present in a manner similar to conventional
Andrew C Harbin, Brett A Styskel, Viren Patel, He Wang, Daniel D Eun   +4 more
doaj   +1 more source

Prognostic Outcomes and Risk Factors for Patients with Renal Cell Carcinoma and Venous Tumor Thrombus after Radical Nephrectomy and Thrombectomy: The Prognostic Significance of Venous Tumor Thrombus Level. [PDF]

, 2015
IntroductionTo evaluate the prognostic outcomes and risk factors for renal cell carcinoma (RCC) patients with venous tumor thrombus in China.Materials and methodsWe reviewed the clinical information of 169 patients who underwent radical nephrectomy and ...
He, Zhisong, Li, Xuesong, Meng, Maxwell, Song, Yi, Tang, Qi, Wang, Jin, Zhang, Qian, Zhou, Liqun   +7 more
core   +4 more sources

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source